People
Clinical Ink is pleased to announce that Jonathan Andrus, Chief Business Officer at Clinical Ink, will receive the 2019 Excellence in Service Award from the Drug Information Association’s (DIA) Americas Regional Advisory Council.
Ms. Poole brings more than 25 years of biopharmaceutical product development and manufacturing experience to Retrophin
Antibe Therapeutics Chief Executive Officer Dan Legault likened developing an effective pain medication that is non-addictive and non-toxic to mountain climbers attempting to climb Mt. Everest.
As senior vice president of global operations, Sridhar will be responsible for integrating business units and provide operational excellence leadership across the Frontage organization
Esperion today announced that the company will participate in analyst-led fireside chats with investors at the following conferences
Peter Rowe, Deep Branch Biotechnology’s co-founder and Commercial Lead, took time to speak with BioSpace about his company, its progress, and where it’s headed.
How Clinical Nurse Educators help patients transition through stages from denial about their illness through to acceptance
CENTOGENE announced the expansion of its executive leadership team with the appointment of Sun Kim in Boston, MA asChief Strategy & Investor Relations Officer.
The Society for Clinical Research Sites announced that Hans Christian Hoeck, president and CEO of Trialcare Research, has joined the organization’s Leadership Council.
The new company celebrated the grand opening of its 100-employee Boston facility that will initially focus its efforts on developing oncology therapies.
PRESS RELEASES